OTCMKTS:ATMS Artemis Therapeutics (ATMS) Stock Price, News & Analysis $0.0021 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$0.0021▼$0.002150-Day Range$0.00▼$0.0352-Week Range$0.11▼$5.00VolumeN/AAverage Volume2,942 shsMarket Capitalization$235,271.40P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Artemis Therapeutics alerts: Email Address Ad Paradigm Press Fmr CIA Advisor reveals PEACEMAKER superweaponKamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.Full details are in this announcement. About Artemis Therapeutics Stock (OTCMKTS:ATMS)Artemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.Read More ATMS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ATMS Stock News HeadlinesSeptember 3, 2024 | yahoo.comArtemis 3 astronauts will walk on the moon with 4G-equipped spacesuitsMarch 30, 2024 | seekingalpha.comITRM Iterum Therapeutics plcSeptember 8, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.October 10, 2023 | theguardian.comMoon a la mode? Prada to design spacesuit for Nasa’s Artemis III missionMay 8, 2023 | msn.comMarker Therapeutics gets new chief medical officerApril 27, 2023 | finance.yahoo.comARTEMIS, a soccer-playing humanoid robot, is ready for the pitchApril 23, 2023 | usatoday.comSpaceX Starship, larger and more powerful than Artemis SLS, explodes on first launch attemptMarch 18, 2023 | theguardian.comNasa reveals new spacesuit for Artemis moon landingSeptember 8, 2024 | Deal Maker (Ad)The solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.January 7, 2023 | finance.yahoo.comArtemis Therapeutics Inc. (ATMS)November 16, 2022 | cbsnews.comNASA managers order review of hurricane-damaged insulation before moon rocket launchNovember 10, 2022 | msn.comNASA’s Artemis I suffers ‘very minor’ damage from NicoleOctober 10, 2022 | reuters.comArtemis Therapeutics IncSeptember 27, 2022 | yahoo.comArtemis I leaves launch pad ahead of Hurricane IanAugust 18, 2022 | news.yahoo.comNasa’s Artemis 1 moon mission explainedAugust 6, 2022 | yahoo.comNASA's Artemis I moon mission includes educational, cultural, and commemorative mementosJune 2, 2022 | finance.yahoo.comNASA Selects New Instruments for Priority Artemis Science on MoonMay 6, 2022 | msn.comWashington plays key role In NASA's Artemis missionsSee More Headlines Receive ATMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Artemis Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Miscellaneous chemical products Sub-IndustryConsumer Goods Current SymbolOTCMKTS:ATMS CUSIPN/A CIK1062128 Webwww.artemis-therapeutics.com Phone(646) 233-1454Fax800-253-5177Employees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,360,000.00 Net Margins-299.54% Pretax Margin-299.54% Return on EquityN/A Return on Assets-425.51% Debt Debt-to-Equity RatioN/A Current Ratio0.15 Quick Ratio0.12 Sales & Book Value Annual Sales$310,000.00 Price / Sales0.76 Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-0.21Miscellaneous Outstanding Shares112,034,000Free Float103,687,000Market Cap$235,271.40 OptionableNot Optionable Beta-1.92 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesShimon CitronChief Executive Officer & DirectorHaim TabakChief Operating OfficerDavid DanaChief Financial OfficerDana WolfChief Medical OfficerKey CompetitorsBergio InternationalOTCMKTS:BRGOGlobal Digital SolutionsOTCMKTS:GDSIGrowLifeOTCMKTS:PHOTAEA-Bridges ImpactOTCMKTS:IMPXUBiologix HairOTCMKTS:BLGXView All Competitors ATMS Stock Analysis - Frequently Asked Questions How have ATMS shares performed this year? Artemis Therapeutics' stock was trading at $0.0720 at the beginning of 2024. Since then, ATMS stock has decreased by 97.1% and is now trading at $0.0021. View the best growth stocks for 2024 here. How do I buy shares of Artemis Therapeutics? Shares of ATMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ATMS) was last updated on 9/8/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artemis Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artemis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
